At the same time, it was found that during the development of tamoxifen resistance, the changes of PI3K/AKT molecules before matrix metallopeptidase overexpression are related to the poor prognosis of breast cancer patients [34]. The gene discussed is AKT1; the disease is breast carcinoma.